CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine

The CSL Limited (ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.

That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.

With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.

CSL and the University of Queensland (UQ) have been working collaboratively on a coronavirus vaccine since the outset of the pandemic.

The sprint to the finish line looks to have been won by the mRNA vaccines developed by Moderna Inc